Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 9
2005 8
2006 9
2007 2
2008 7
2009 9
2010 4
2011 9
2012 15
2013 11
2014 7
2015 8
2016 13
2017 11
2018 15
2019 15
2020 10
2021 10
2022 13
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers.
Strum S, Andersen MH, Svane IM, Siu LL, Weber JS. Strum S, et al. Among authors: andersen mh. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e438592. doi: 10.1200/EDBK_438592. Am Soc Clin Oncol Educ Book. 2024. PMID: 38669611 Free article. Review.
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Glöckner HJ, Martinenaite E, Landkildehus Lisle T, Grauslund J, Ahmad S, Met Ö, Thor Straten P, Hald Andersen M. Glöckner HJ, et al. Among authors: hald andersen m. Oncoimmunology. 2024 Feb 22;13(1):2318053. doi: 10.1080/2162402X.2024.2318053. eCollection 2024. Oncoimmunology. 2024. PMID: 38404966 Free PMC article.
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
Holmström MO, Andersen M, Traynor S, Ahmad SM, Lisle TL, Handlos Grauslund J, Skov V, Kjær L, Ottesen JT, Gjerstorff MF, Hasselbalch HC, Andersen MH. Holmström MO, et al. Among authors: andersen mh. Front Immunol. 2023 Aug 17;14:1240678. doi: 10.3389/fimmu.2023.1240678. eCollection 2023. Front Immunol. 2023. PMID: 37662956 Free PMC article.
Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.
Hulen TM, Friese C, Kristensen NP, Granhøj JS, Borch TH, Peeters MJW, Donia M, Andersen MH, Hadrup SR, Svane IM, Met Ö. Hulen TM, et al. Among authors: andersen mh. Front Immunol. 2023 Jun 8;14:1180997. doi: 10.3389/fimmu.2023.1180997. eCollection 2023. Front Immunol. 2023. PMID: 37359554 Free PMC article.
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
Mørk SK, Kongsted P, Westergaard MCW, Albieri B, Granhøj JS, Donia M, Martinenaite E, Holmström MO, Madsen K, Kverneland AH, Kjeldsen JW, Holmstroem RB, Lorentzen CL, Nørgaard N, Andreasen LV, Wood GK, Christensen D, Klausen MS, Hadrup SR, Thor Straten P, Andersen MH, Svane IM. Mørk SK, et al. Among authors: andersen mh. Front Immunol. 2023 Mar 14;14:1122977. doi: 10.3389/fimmu.2023.1122977. eCollection 2023. Front Immunol. 2023. PMID: 36999039 Free PMC article.
Novel immune modulatory vaccines targeting TGFβ.
Andersen MH. Andersen MH. Cell Mol Immunol. 2023 May;20(5):551-553. doi: 10.1038/s41423-023-01000-5. Epub 2023 Mar 27. Cell Mol Immunol. 2023. PMID: 36973484 Free PMC article. No abstract available.
176 results